These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23794010)

  • 21. Analysis and assay of oseltamivir-resistant mutants of influenza neuraminidase via direct observation of drug unbinding and rebinding in simulation.
    Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ
    Biochemistry; 2013 Nov; 52(45):8150-64. PubMed ID: 24128064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
    Wang SQ; Du QS; Chou KC
    Biochem Biophys Res Commun; 2007 Mar; 354(3):634-40. PubMed ID: 17266937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.
    Collins PJ; Haire LF; Lin YP; Liu J; Russell RJ; Walker PA; Skehel JJ; Martin SR; Hay AJ; Gamblin SJ
    Nature; 2008 Jun; 453(7199):1258-61. PubMed ID: 18480754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase.
    Wang P; Zhang JZ
    J Phys Chem B; 2010 Oct; 114(40):12958-64. PubMed ID: 20860351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular prediction of oseltamivir efficiency against probable influenza A (H1N1-2009) mutants: molecular modeling approach.
    Rungrotmongkol T; Malaisree M; Nunthaboot N; Sompornpisut P; Hannongbua S
    Amino Acids; 2010 Jul; 39(2):393-8. PubMed ID: 20037767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
    Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
    J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX; Zheng JJ
    Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
    Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
    Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
    Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
    Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).
    Mihajlovic ML; Mitrasinovic PM
    Biophys Chem; 2008 Aug; 136(2-3):152-8. PubMed ID: 18584938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
    Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P
    Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt.
    Earhart KC; Elsayed NM; Saad MD; Gubareva LV; Nayel A; Deyde VM; Abdelsattar A; Abdelghani AS; Boynton BR; Mansour MM; Essmat HM; Klimov A; Shuck-Lee D; Monteville MR; Tjaden JA
    J Infect Public Health; 2009; 2(2):74-80. PubMed ID: 20701864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivir.
    Gillman A; Muradrasoli S; Söderström H; Nordh J; Bröjer C; Lindberg RH; Latorre-Margalef N; Waldenström J; Olsen B; Järhult JD
    PLoS One; 2013; 8(8):e71230. PubMed ID: 23951116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
    Hussain Basha S; Prasad RN
    BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsecond dynamics of H10N7 influenza neuraminidase reveals the plasticity of loop regions and drug resistance due to the R292K mutation.
    Sk MF; Samanta S; Poddar S; Kar P
    J Comput Chem; 2024 Feb; 45(5):247-263. PubMed ID: 37787086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis of drug resistance in A/H1N1 virus.
    Vergara-Jaque A; Poblete H; Lee EH; Schulten K; González-Nilo F; Chipot C
    J Chem Inf Model; 2012 Oct; 52(10):2650-6. PubMed ID: 22978683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel binding patterns between ganoderic acids and neuraminidase: Insights from docking, molecular dynamics and MM/PBSA studies.
    Yang Z; Wu F; Yuan X; Zhang L; Zhang S
    J Mol Graph Model; 2016 Apr; 65():27-34. PubMed ID: 26905206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.